Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer

• Principais autores: Le Deng (Autor), Qipeng Huang (Autor), Jiang Wang (Autor), Kaiping Luo (Autor), Jiarong Liu (Autor), Wenjun Yan (Autor), Fang Jiang (Autor), Gaosi Xu (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: This study aimed to evaluate clinical features and prognosis and therapy option of patients with different risk ranks based on antibody against the M-type phospholipase-A2-receptor (PLA2Rab) level in seropositive M-type phospholipase-A2-receptor (PLA2R)-associated membranous nephropathy...